Physician

Adam David Mark, O.D.

According to 2025 Medicare claims, Adam Mark, O.D. (NPI: 1275537961) practices optometrist in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is STEVE H. SILBERBERG, O.D., LLC (NPI: 1851621403) and primary practice location at 07747-3283.

Mark's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 279 traditional Medicare patients, billed 625 HCPCS/CPT codes, and received $41,757 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 383 prescription claims across 111 beneficiaries totaling $85,885 in drug costs, led by Vyzulta (Latanoprostene Bunod). Open Payments data shows 7 records totaling $231. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $29,697 to $41,757. Similarly, Part D prescription costs have moved sharply higher in recent years, from $15,418 to $85,885. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$42K2015 Medicare payment: $29,697 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $26,588 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $23,807 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $23,049 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $31,200 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $29,792 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $37,001 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $36,398 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $38,159 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $41,757 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015165489$29,697
2016168435$26,588
2017154425$23,807
2018166414$23,049
2019206539$31,200
2020212465$29,792
2021226546$37,001
2022243542$36,398
2023270566$38,159
2024279625$41,757

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$43K$86K2015 Drug cost: $15,418 (USD; Tot_Drug_Cst)2016 Drug cost: $26,262 (USD; Tot_Drug_Cst)2017 Drug cost: $28,151 (USD; Tot_Drug_Cst)2018 Drug cost: $35,316 (USD; Tot_Drug_Cst)2019 Drug cost: $37,770 (USD; Tot_Drug_Cst)2020 Drug cost: $44,059 (USD; Tot_Drug_Cst)2021 Drug cost: $75,197 (USD; Tot_Drug_Cst)2022 Drug cost: $62,818 (USD; Tot_Drug_Cst)2023 Drug cost: $71,990 (USD; Tot_Drug_Cst)2024 Drug cost: $85,885 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201534124$15,418
201644134$26,262
201744145$28,151
201854161$35,316
201962164$37,770
202059211$44,059
202173282$75,197
202278310$62,818
202385310$71,990
2024111383$85,885

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system193197$89
92012Established patient problem focused exam of visual system102150$66
92083Exam of visual field with extended testing6472$48
92134Imaging of retina5462$31
92133Imaging of optic nerve5660$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyzultaLatanoprostene Bunod512,062$23,916
LumiganBimatoprost452,042$17,663
TravoprostTravoprost16920$3,994
Loteprednol EtabonateLoteprednol Etabonate14452$3,080
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat603,152$1,019

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$231Tarsus Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam David Mark, O.D.?

Tedicare shows public-source Medicare data for Adam David Mark, O.D. (NPI 1275537961), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam David Mark, O.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam David Mark, O.D.?

Adam David Mark, O.D. is linked to STEVE H. SILBERBERG, O.D., LLC (billing NPI 1851621403) in the available physician profile data.

Does Adam David Mark, O.D. have Open Payments data?

Adam David Mark, O.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.